Review



primary antibodies against canx  (Danaher Inc)


Bioz Verified Symbol Danaher Inc is a verified supplier
Bioz Manufacturer Symbol Danaher Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Danaher Inc primary antibodies against canx
    Sequence of all genes.
    Primary Antibodies Against Canx, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against canx/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    primary antibodies against canx - by Bioz Stars, 2026-02
    86/100 stars

    Images

    1) Product Images from "n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin"

    Article Title: n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin

    Journal: Journal of Cancer

    doi: 10.7150/jca.89135

    Sequence of all genes.
    Figure Legend Snippet: Sequence of all genes.

    Techniques Used: Sequencing

    circFAM126A sponges miR-505-3p to upregulate CANX. A: Bioinformatics websites PITA, microT, TargetScan, PicTar, and the miRanda database were utilized to predict potential downstream mRNA targets of miR-505-3p. B and C: The impact of knocking down or overexpressing miR-505-3p on the mRNA and protein expression of CANX was examined using RT-qPCR and Western blot. D: Dual-luciferase reporter assay was conducted to investigate the target relationship between miR-505-3p and CANX. E: The bioinformatics website starbase was employed to predict potential binding sites between CANX and miR-505-3p. F: Biotinylated pull-down assay was used to analyze the targeting relationship between miR-505-3p and CANX. G and H: RT-qPCR and Western blot assays were carried out to measure the mRNA and protein expression of CANX in PCa tissues and adjacent normal tissues. I and J: Pearson correlation analysis was performed to assess the relationship among CircFAM126A, miR-505-3p, and CANX in cancer tissues. K and L: The effect of knocking down CircFAM126A on the mRNA and protein levels of CANX was detected using RT-qPCR and Western blot. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.
    Figure Legend Snippet: circFAM126A sponges miR-505-3p to upregulate CANX. A: Bioinformatics websites PITA, microT, TargetScan, PicTar, and the miRanda database were utilized to predict potential downstream mRNA targets of miR-505-3p. B and C: The impact of knocking down or overexpressing miR-505-3p on the mRNA and protein expression of CANX was examined using RT-qPCR and Western blot. D: Dual-luciferase reporter assay was conducted to investigate the target relationship between miR-505-3p and CANX. E: The bioinformatics website starbase was employed to predict potential binding sites between CANX and miR-505-3p. F: Biotinylated pull-down assay was used to analyze the targeting relationship between miR-505-3p and CANX. G and H: RT-qPCR and Western blot assays were carried out to measure the mRNA and protein expression of CANX in PCa tissues and adjacent normal tissues. I and J: Pearson correlation analysis was performed to assess the relationship among CircFAM126A, miR-505-3p, and CANX in cancer tissues. K and L: The effect of knocking down CircFAM126A on the mRNA and protein levels of CANX was detected using RT-qPCR and Western blot. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Techniques Used: Expressing, Quantitative RT-PCR, Western Blot, Luciferase, Reporter Assay, Binding Assay, Pull Down Assay

    CANX overexpression re-activates cancer malignancy after inhibition of circFAM126A or overexpression of miR-505-3p. Sh-circFAM126A and miR-505-3p mimic were co-transfected into PC-3 and DU145 cells. A: The impact of co-transfection on miR-505-3p levels in cells was measured using RT-qPCR. B: Cell proliferation rate was assessed through the CCK-8 assay. C: Colony formation assay was conducted to evaluate the cell proliferation capacity. D: EdU incorporation was used to detect the rate of Edu-positive cells. E: Flow cytometry was performed to examine cell apoptosis. F and G: Transwell assays were utilized to assess the migration and invasion capabilities of the cells. H and I: Commercial kits were employed to measure the levels of TG and cholesterol in the cells. J and K: mRNA levels of LUR1 and SREBPs in the cells were detected by RT-qPCR. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.
    Figure Legend Snippet: CANX overexpression re-activates cancer malignancy after inhibition of circFAM126A or overexpression of miR-505-3p. Sh-circFAM126A and miR-505-3p mimic were co-transfected into PC-3 and DU145 cells. A: The impact of co-transfection on miR-505-3p levels in cells was measured using RT-qPCR. B: Cell proliferation rate was assessed through the CCK-8 assay. C: Colony formation assay was conducted to evaluate the cell proliferation capacity. D: EdU incorporation was used to detect the rate of Edu-positive cells. E: Flow cytometry was performed to examine cell apoptosis. F and G: Transwell assays were utilized to assess the migration and invasion capabilities of the cells. H and I: Commercial kits were employed to measure the levels of TG and cholesterol in the cells. J and K: mRNA levels of LUR1 and SREBPs in the cells were detected by RT-qPCR. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Techniques Used: Over Expression, Inhibition, Transfection, Cotransfection, Quantitative RT-PCR, CCK-8 Assay, Colony Assay, Flow Cytometry, Migration



    Similar Products

    primary antibody against canx  (Proteintech)
    96
    Proteintech primary antibody against canx
    Primary Antibody Against Canx, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against canx/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibody against canx - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    primary antibodies against canx  (Danaher Inc)
    86
    Danaher Inc primary antibodies against canx
    Sequence of all genes.
    Primary Antibodies Against Canx, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against canx/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    primary antibodies against canx - by Bioz Stars, 2026-02
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Sequence of all genes.

    Journal: Journal of Cancer

    Article Title: n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin

    doi: 10.7150/jca.89135

    Figure Lengend Snippet: Sequence of all genes.

    Article Snippet: Primary antibodies against CANX (1:1000, ab22595, Abcam), insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1, 1:1000, ab82968, Abcam), Vascular endothelial growth factor (VEGF, 1:1000, sc-7269, Santa Cruz Biotechnology), programmed death-ligand 1 (PD-L1, 1:1000, 13684, Cell Signaling Technology), and GAPDH (1:1000; ab37168, Abcam) were incubated with the membrane at 4°C overnight, and horseradish peroxidase-linked secondary antibody (1:500; SC-2054; Santa Cruz Biotechnology) was added for 2 h at room temperature.

    Techniques: Sequencing

    circFAM126A sponges miR-505-3p to upregulate CANX. A: Bioinformatics websites PITA, microT, TargetScan, PicTar, and the miRanda database were utilized to predict potential downstream mRNA targets of miR-505-3p. B and C: The impact of knocking down or overexpressing miR-505-3p on the mRNA and protein expression of CANX was examined using RT-qPCR and Western blot. D: Dual-luciferase reporter assay was conducted to investigate the target relationship between miR-505-3p and CANX. E: The bioinformatics website starbase was employed to predict potential binding sites between CANX and miR-505-3p. F: Biotinylated pull-down assay was used to analyze the targeting relationship between miR-505-3p and CANX. G and H: RT-qPCR and Western blot assays were carried out to measure the mRNA and protein expression of CANX in PCa tissues and adjacent normal tissues. I and J: Pearson correlation analysis was performed to assess the relationship among CircFAM126A, miR-505-3p, and CANX in cancer tissues. K and L: The effect of knocking down CircFAM126A on the mRNA and protein levels of CANX was detected using RT-qPCR and Western blot. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Journal: Journal of Cancer

    Article Title: n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin

    doi: 10.7150/jca.89135

    Figure Lengend Snippet: circFAM126A sponges miR-505-3p to upregulate CANX. A: Bioinformatics websites PITA, microT, TargetScan, PicTar, and the miRanda database were utilized to predict potential downstream mRNA targets of miR-505-3p. B and C: The impact of knocking down or overexpressing miR-505-3p on the mRNA and protein expression of CANX was examined using RT-qPCR and Western blot. D: Dual-luciferase reporter assay was conducted to investigate the target relationship between miR-505-3p and CANX. E: The bioinformatics website starbase was employed to predict potential binding sites between CANX and miR-505-3p. F: Biotinylated pull-down assay was used to analyze the targeting relationship between miR-505-3p and CANX. G and H: RT-qPCR and Western blot assays were carried out to measure the mRNA and protein expression of CANX in PCa tissues and adjacent normal tissues. I and J: Pearson correlation analysis was performed to assess the relationship among CircFAM126A, miR-505-3p, and CANX in cancer tissues. K and L: The effect of knocking down CircFAM126A on the mRNA and protein levels of CANX was detected using RT-qPCR and Western blot. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Article Snippet: Primary antibodies against CANX (1:1000, ab22595, Abcam), insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1, 1:1000, ab82968, Abcam), Vascular endothelial growth factor (VEGF, 1:1000, sc-7269, Santa Cruz Biotechnology), programmed death-ligand 1 (PD-L1, 1:1000, 13684, Cell Signaling Technology), and GAPDH (1:1000; ab37168, Abcam) were incubated with the membrane at 4°C overnight, and horseradish peroxidase-linked secondary antibody (1:500; SC-2054; Santa Cruz Biotechnology) was added for 2 h at room temperature.

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Luciferase, Reporter Assay, Binding Assay, Pull Down Assay

    CANX overexpression re-activates cancer malignancy after inhibition of circFAM126A or overexpression of miR-505-3p. Sh-circFAM126A and miR-505-3p mimic were co-transfected into PC-3 and DU145 cells. A: The impact of co-transfection on miR-505-3p levels in cells was measured using RT-qPCR. B: Cell proliferation rate was assessed through the CCK-8 assay. C: Colony formation assay was conducted to evaluate the cell proliferation capacity. D: EdU incorporation was used to detect the rate of Edu-positive cells. E: Flow cytometry was performed to examine cell apoptosis. F and G: Transwell assays were utilized to assess the migration and invasion capabilities of the cells. H and I: Commercial kits were employed to measure the levels of TG and cholesterol in the cells. J and K: mRNA levels of LUR1 and SREBPs in the cells were detected by RT-qPCR. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Journal: Journal of Cancer

    Article Title: n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin

    doi: 10.7150/jca.89135

    Figure Lengend Snippet: CANX overexpression re-activates cancer malignancy after inhibition of circFAM126A or overexpression of miR-505-3p. Sh-circFAM126A and miR-505-3p mimic were co-transfected into PC-3 and DU145 cells. A: The impact of co-transfection on miR-505-3p levels in cells was measured using RT-qPCR. B: Cell proliferation rate was assessed through the CCK-8 assay. C: Colony formation assay was conducted to evaluate the cell proliferation capacity. D: EdU incorporation was used to detect the rate of Edu-positive cells. E: Flow cytometry was performed to examine cell apoptosis. F and G: Transwell assays were utilized to assess the migration and invasion capabilities of the cells. H and I: Commercial kits were employed to measure the levels of TG and cholesterol in the cells. J and K: mRNA levels of LUR1 and SREBPs in the cells were detected by RT-qPCR. Data are presented as mean ± SD (n = 3), with * P < 0.05 indicating statistical significance.

    Article Snippet: Primary antibodies against CANX (1:1000, ab22595, Abcam), insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1, 1:1000, ab82968, Abcam), Vascular endothelial growth factor (VEGF, 1:1000, sc-7269, Santa Cruz Biotechnology), programmed death-ligand 1 (PD-L1, 1:1000, 13684, Cell Signaling Technology), and GAPDH (1:1000; ab37168, Abcam) were incubated with the membrane at 4°C overnight, and horseradish peroxidase-linked secondary antibody (1:500; SC-2054; Santa Cruz Biotechnology) was added for 2 h at room temperature.

    Techniques: Over Expression, Inhibition, Transfection, Cotransfection, Quantitative RT-PCR, CCK-8 Assay, Colony Assay, Flow Cytometry, Migration